Yıl: 2022 Cilt: 24 Sayı: 2 Sayfa Aralığı: 122 - 129 Metin Dili: Türkçe DOI: 10.14744/ejp.2022.9021 İndeks Tarihi: 13-09-2022

Anxiety/depression scores and affecting factors in COPD patients

Öz:
BACKGROUND AND AIM: Mental disorders are common in chronic obstructive pulmonary disease (COPD) patients. In this study; anxiety/depression and affecting factors in COPD patients were examined. METHODS: COPD patients who applied to Akdeniz University Chest Diseases clinic between November 2019 and March 2020 were included in the study. The diagnosis and staging were assessed according to the Global Initiative for Chronic Obstructive Lung Disease 2020 (GOLD- 2020). The data were collected via face-to-face interviews using the patient description form. In addition, COPD assessment test (CAT), modified-medical research council (m-MRC), and hospital anxiety and depression (HAD) scale were applied to the patients. Anxiety/depression status was assessed using HAD scale. We evaluated the relationship between HAD scores and questionnaire and clinical findings. The data were analyzed in SPSS 22.0 program. x2, ANOVA, Kruskal-Wallis, Student’s t-test, and Mann–Whitney-U test were used. Correlation and linear regression analysis were used. RESULTS: The majority of the 151 patients were male (84.8%), mean age was 66.1±9.5 years, and 27% were active smokers. Most of the patients had comorbidity (76.8%) and 4.6% of the patients reported that they had a psychiatric illness. The HAD-anxiety score was 4.70±4.03, and the HAD-depression score was 4.98±3.50. Depression and anxiety rates were 21.6% and 8.6%, respectively. The prevalence of anxiety and/or depression was found to be 23.7%. Multivariate analysis showed that the presence of comorbidity, severe COPD, and the number of complaints are the effective factors for both anxiety and depression. CAT and m-MRC scores were significantly correlated with HAD scores. CONCLUSIONS: Anxiety/depression was found five times more than that reported. Severe COPD, more complaints, and comorbidity were risk factors for anxiety/depression.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397–412.
  • 2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765–73.
  • 3. Mah L, Szabuniewicz C, Fiocco AJ. Can anxiety damage the brain? Curr Opin Psychiatry 2016;29:56–63.
  • 4. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006;100:1767–74.
  • 5. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008;38:385–96.
  • 6. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020, p. 21–42. Available at: http://www.goldcopd.org. Accessed Feb 22, 2022.
  • 7. Aydemir Ö, Güvenir T, Küey L, Kültür S. Reliability and validity of the Turkish version of hospital anxiety and depression. Turk Psikiyatri Derg 1997;8:280–7.
  • 8. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 2010;7:e1000220.
  • 9. Elassal G, Elsheikh M, Gawad A, Zeid AGA. Assessment of depression and anxiety symptoms in chronic obstructive pulmonary disease patients: A case – control study. Egypt J Chest Dis Tuberc 2014;63:575–82.
  • 10. Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population- based cohort study. Respir Med 2016;117:33–9.
  • 11. Willgoss TG, Yohannes AM, Goldbart J, Fatoye F. “Everything was spiraling out of control”: experiences of anxiety in people with chronic obstructive pulmonary disease. Heart Lung 2012;41:562–71.
  • 12. Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008;31:667–77.
  • 13. Tselebis A, Bratis D, Pachi A, Moussas G, Ilias I, Harikiopoulou M. et al, Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). In: Zirimis L, Papazoglakis A, editors. Chronic Obstructive Pulmonary Disease: New Research. New York, Nova Science Publishers; 2013. p. 15–40.
  • 14. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004;58:65–70.
  • 15. Yıldız M, Mirici A, Gönlügür U, Çakır DÜ, Öyekçin DG, Akbaş B. Effect of depression and anxiete on quality of life and exercise tolerance in COPD. Journal of İzmir Chest Hospital 2016; 30: 81-87.
  • 16. Aydemir Y, Doğu Ö, Amasya A, Yazgan B, Gazioğlu EÖ, Gündüz H. Evaluation of anxiety and depression with patient characteristics in patients with chronic respiratory and heart disease. Sakarya Medical Journal 2015;5:199–203.
  • 17. Akkuş Y, Karabulutlu EY, Yağcı S. the effect of anxiety-depression on the cognitive status in patients with chronic obstructive diseases. Kırıkkale University Medical Faculty Journal 2016;18:94–100.
  • 18. Kapısız Ö, Eker F. Evaluation of the relationship between the levels and perceptions of dyspnea and the levels of anxiety and depression in chronic obstructive pulmonary disease (COPD) patients. J Psychiatric Nurs 2018;9:88–95.
  • 19. Anar C, Tatar D, Geduktap E, Yildirim Y, Halilcolar H. Frequency of anxiety-depression among chronic obstructive pulmonary disease (COPD) patients who use home oxygen therapy. İzmir Chest Hospital Journal 2021;26:83–9.
  • 20. Asnaashari AM, Talaei A, Haghigh B. Evaluation of psychological status in patients with asthma and COPD. Iran J Allergy Asthma Immunol 2012;11:65–71.
  • 21. Puhan MA, Frey M, Büchi S, Schünemann HJ. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2008;6:46.
  • 22. Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001;21:80–6.
  • 23. Gökçek Ö, Hüzmeli ED, Katayıfçı N. The effect of dsypnea on quality of life and depression in patients with chronic obstructive pulmonary. Acıbadem University Health Sciences Journal 2019;10:84– 8.
  • 24. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167:60–7.
  • 25. Cooper CB. Determining the role of exercise in patients with chronic pulmonary disease. Med Sci Sports Exerc 1995;27:147–57.
  • 26. Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 1996;154:6–17.
  • 27. Pascal OI, Trofor AC, Lotrean LM, Filipeanu D, Trofor L. Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life. Tob Induc Dis 2017;15:23.
APA Bozkurt N, Bozkurt A, DIROL H (2022). Anxiety/depression scores and affecting factors in COPD patients. , 122 - 129. 10.14744/ejp.2022.9021
Chicago Bozkurt Nurgul,Bozkurt Ali İhsan,DIROL HULYA Anxiety/depression scores and affecting factors in COPD patients. (2022): 122 - 129. 10.14744/ejp.2022.9021
MLA Bozkurt Nurgul,Bozkurt Ali İhsan,DIROL HULYA Anxiety/depression scores and affecting factors in COPD patients. , 2022, ss.122 - 129. 10.14744/ejp.2022.9021
AMA Bozkurt N,Bozkurt A,DIROL H Anxiety/depression scores and affecting factors in COPD patients. . 2022; 122 - 129. 10.14744/ejp.2022.9021
Vancouver Bozkurt N,Bozkurt A,DIROL H Anxiety/depression scores and affecting factors in COPD patients. . 2022; 122 - 129. 10.14744/ejp.2022.9021
IEEE Bozkurt N,Bozkurt A,DIROL H "Anxiety/depression scores and affecting factors in COPD patients." , ss.122 - 129, 2022. 10.14744/ejp.2022.9021
ISNAD Bozkurt, Nurgul vd. "Anxiety/depression scores and affecting factors in COPD patients". (2022), 122-129. https://doi.org/10.14744/ejp.2022.9021
APA Bozkurt N, Bozkurt A, DIROL H (2022). Anxiety/depression scores and affecting factors in COPD patients. Eurasian Journal of Pulmonology, 24(2), 122 - 129. 10.14744/ejp.2022.9021
Chicago Bozkurt Nurgul,Bozkurt Ali İhsan,DIROL HULYA Anxiety/depression scores and affecting factors in COPD patients. Eurasian Journal of Pulmonology 24, no.2 (2022): 122 - 129. 10.14744/ejp.2022.9021
MLA Bozkurt Nurgul,Bozkurt Ali İhsan,DIROL HULYA Anxiety/depression scores and affecting factors in COPD patients. Eurasian Journal of Pulmonology, vol.24, no.2, 2022, ss.122 - 129. 10.14744/ejp.2022.9021
AMA Bozkurt N,Bozkurt A,DIROL H Anxiety/depression scores and affecting factors in COPD patients. Eurasian Journal of Pulmonology. 2022; 24(2): 122 - 129. 10.14744/ejp.2022.9021
Vancouver Bozkurt N,Bozkurt A,DIROL H Anxiety/depression scores and affecting factors in COPD patients. Eurasian Journal of Pulmonology. 2022; 24(2): 122 - 129. 10.14744/ejp.2022.9021
IEEE Bozkurt N,Bozkurt A,DIROL H "Anxiety/depression scores and affecting factors in COPD patients." Eurasian Journal of Pulmonology, 24, ss.122 - 129, 2022. 10.14744/ejp.2022.9021
ISNAD Bozkurt, Nurgul vd. "Anxiety/depression scores and affecting factors in COPD patients". Eurasian Journal of Pulmonology 24/2 (2022), 122-129. https://doi.org/10.14744/ejp.2022.9021